Tpl2 ablation leads to increased gene expression of EGFR, HER2, and HER3 in Tpl2−/− keratinocytes and increased EGFR, p-EGFR, and HER2 protein levels in Tpl2−/− papillomas. This evidence concerns the gene MAP3K8 and papilloma.